The store will not work correctly when cookies are disabled.
1-(2-methoxyphenethyl)-5-phenyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
ID: ALA4285539
PubChem CID: 145990603
Max Phase: Preclinical
Molecular Formula: C20H22N4O
Molecular Weight: 334.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1CCn1nnc2c1CCN(c1ccccc1)C2
Standard InChI: InChI=1S/C20H22N4O/c1-25-20-10-6-5-7-16(20)11-14-24-19-12-13-23(15-18(19)21-22-24)17-8-3-2-4-9-17/h2-10H,11-15H2,1H3
Standard InChI Key: PNMMPJOTCMZYDV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
34.0796 -3.2024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2856 -3.3697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7394 -2.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9350 -2.9302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3849 -2.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6467 -1.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4469 -1.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9895 -1.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6850 -3.7086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8873 -3.8775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6332 -4.6518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1153 -5.3161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6332 -5.9802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8552 -5.7278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1452 -6.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4392 -5.7278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4392 -4.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1452 -4.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8552 -4.9045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7297 -6.1324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0242 -5.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3147 -6.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3147 -6.9395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0140 -7.3560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7297 -6.9533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
4 3 2 0
4 5 1 0
6 5 2 0
7 6 1 0
8 7 2 0
3 8 1 0
4 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
15 14 1 0
16 15 1 0
16 17 1 0
18 17 1 0
19 18 1 0
14 19 2 0
11 19 1 0
20 16 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
20 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.42 | Molecular Weight (Monoisotopic): 334.1794 | AlogP: 3.09 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.83 | CX LogP: 3.52 | CX LogD: 3.52 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -1.39 |
References
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |